Allison Krugman - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Allison Krugman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Allison Krugman

Allison Krugman

Verified

Staff Editor, Data Visuals, Think Global Health

Brooklyn, New York

Final Covers

Women's Health, Nutrition Fitness, Profiles Mental Health,Health Wellness

Doesn’t Cover

Tech, cars

Journalist Type

-

Seniority Positions

-

Industries

-

Medium Formats

-

Content

Total articles 18

  • DRC in Crisis: The Human Cost of U.S. Aid Cuts Amid the M23 Rebellion

    By Allison Krugman| Think Global Health@ In the six weeks since M23 rebels in Democratic Republic of Congo staged a violent takeover of Goma, a major humanitarian and minerals trading hub in the eastern part of the country, horrific bouts of violence and a sprawling humanitarian crisis have unfolded across the region. The conflict has spawned mass displacement, cuts to water and electricity, and direct attacks on health-care operations.  "When the military left . . ., they opened the weapons stock.

    By Allison Krugman · Think Global Health

    Mar. 20, 2025

  • A "Defining Moment" for Global Health Funding

    By Allison Krugman| Think Global Health@ President Donald Trump's recent maneuvers to gut the United States Agency for International Development (USAID) and withdraw the country from the World Health Organization (WHO) have sent shockwaves through the global health community.  The decision to immediately stem global aid flows unleashed a "state of confusion" about how programs will operate and how other major donors and development partners will respond.

    By Allison Krugman · Think Global Health

    Feb. 13, 2025

  • Importing Generic Drugs Could Ease U.S. Shortages

    By Chloe Searchinger, Allison Krugman, Thomas J. Bollyky| Think Global Health@ Syphilis rates have been rising in the United States for 10 years. If untreated, the disease poses grim risks, from heart and brain damage to blindness to miscarriage and infant death. Yet when the U.S. Food and Drug Administration (FDA) announced a shortage of benzathine penicillin G—the only approved treatment for pregnant women—in 2023, the agency waited nine months before importing a version of the drug from a French pharmaceutical company approved for use in Europe.

    By Chloe Searchinger, Allison Krugman, Thomas J. Bollyky · Think Global Health

    Jan. 17, 2025

As seen in

Company Info

Think Global Health

Welcome. This page is part of a health information initiative where we deliver content on global health in bite-sized pieces. We hope to engage with other public health and global health professionals with our content.

Brooklyn, New York, United States